Opus Genetics, Inc. has grown revenue −40% a year over three years. Revenue growth, 3-year annual rate: −40% (Biotechnology median +17%). Years of annual history on file: 24, FY2002 to FY2025, as filed.

IRDOpus Genetics, Inc.

Healthcare

$4.45+119% 1Y

$4.45

$1.7452 weeks$6.09

Is it growing?

Watch

Growth is fading: revenue shrinking (−36% year on year) and operating margin narrowing (−446.9 points).

2 to watch, 1 without data

Revenue trend−36% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction−446.9 points operating

Trailing-twelve-month operating margin, -853.7% now against -406.8% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.